OverviewSuggest Edit

IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. More recently, the company has made the strategic decision to enter the oral film market and are in the process of implementing commercial oral film manufacturing capability. This enables IntelGenx to offer its partners a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing.

TypePublic
Founded2003
HQSaint-Laurent, CA
Websiteintelgenx.com

Latest Updates

Employees (est.) (Dec 2018)38(+19%)
Revenue (FY, 2018)$1.8 M(-64%)
Share Price (Oct 2017)$0.7 (-2%)

IntelGenx Office Locations

IntelGenx has an office in Saint-Laurent
Saint-Laurent, CA (HQ)
6420 Rue Abrams
Show all (1)

IntelGenx Financials and Metrics

IntelGenx Revenue

IntelGenx's revenue was reported to be $1.82 m in FY, 2018
USD

Revenue (Q2, 2019)

197.0k

Net income (Q2, 2019)

(2.6m)

EBIT (Q2, 2019)

(2.3m)

Market capitalization (31-Oct-2017)

50.1m

Closing stock price (31-Oct-2017)

0.7

Cash (30-Jun-2019)

5.6m

EV

46.1m
IntelGenx's current market capitalization is $50.1 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

948.0k5.1m5.2m5.2m1.8m

Revenue growth, %

2%

General and administrative expense

2.0m2.1m3.6m4.0m5.0m

R&D expense

561.0k1.0m1.8m2.6m5.1m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

5.0m4.4m2.9m612.0k1.6m6.8m

Accounts Receivable

144.0k652.0k1.1m1.0m623.0k815.0k

Inventories

375.0k

Current Assets

5.6m5.3m4.2m6.4m6.0m13.1m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

2.6k5.2k5.2m4.4m3.8m2.7m2.3m2.1m1.1m2.7m300.0k1.2m1.6m618.0k2.3m1.7m6.6m5.6m

Accounts Receivable

55.026.053.0k52.0k76.0k115.0k878.0k490.0k750.0k211.0k428.0k367.0k470.0k655.0k485.0k592.0k674.0k466.0k

Inventories

383.0k391.0k

Current Assets

3.0k5.6k5.5m4.7m4.1m2.9m3.3m2.8m2.1m6.6m5.0m3.8m7.9m3.8m5.2m4.1m10.6m8.0m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(1.6m)(1.7m)1.3m(1.2m)(3.1m)

Depreciation and Amortization

72.0k74.0k171.0k511.0k

Accounts Payable

1.1m(698.0k)408.0k

Cash From Operating Activities

(1.2m)(1.4m)546.0k1.7m(4.4m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q1, 2019Q2, 2019

Net Income

(442.0)(434.0k)(54.0k)(328.0k)1.0m(746.0k)(1.6m)(1.6m)(512.0k)(1.2m)(782.0k)(2.3m)(2.4m)(2.6m)(5.2m)

Depreciation and Amortization

16.018.0k17.0k16.0k32.0k48.0k87.0k187.0k361.0k170.0k340.0k183.0k179.0k

Accounts Payable

(309.0)(17.0k)1.0k138.0k874.0k(860.0k)(438.0k)(769.0k)(284.0k)(445.0k)770.0k40.0k199.0k(501.0k)(635.0k)

Cash From Operating Activities

(411.0)(615.0k)(474.0k)(279.0k)(479.0k)494.0k(1.1m)(1.7m)3.0m(523.0k)(2.0m)(2.2m)(1.5m)(2.4m)(4.7m)
USDY, 2019

EV/EBIT

-19.7 x

EV/CFO

-9.8 x

Financial Leverage

2.9 x
Show all financial metrics

IntelGenx Online and Social Media Presence

Embed Graph

IntelGenx News and Updates

IntelGenx to Report Second Quarter 2019 Financial Results on August 8, 2019 – Conference Call to Follow

SAINT LAURENT, Quebec, Aug. 01, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its second quarter 2019 financial results after market close on August 8, 2019.

IntelGenx Grants Stock Options

SAINT LAURENT, Quebec, March 27, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTC.QX:IGXT) announced today that the Company’s board of directors granted 100,000 options to acquire 100,000 common shares under the 2016 Stock Option Plan to Rodol…

IntelGenx Reports Fourth Quarter and Full-Year 2018 Financial Results

SAINT LAURENT, Quebec, March 22, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter and twelve-month periods ended December 31, 2018. All dollar amounts are expressed in U.S. currency …

CORRECTION - IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 22, 2019 – Conference Call to Follow on March 25, 2019

SAINT LAURENT, Quebec, March 18, 2019 (GLOBE NEWSWIRE) -- In a release issued under a similar headline earlier today by IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT), please note that the financial results will be reported on March 22nd, after market hours, and that the conference cal…

Global Oral Dissolvable Films Market : Key Players are MonoSol Rx, Tesa Labtec GmbH, IntelGenX, BioDelivery Sciences, Cynapsus Therapeutics

Oral Dissolvable Films Market report provides in-depth statistics and analysis available on the market status of the Oral Dissolvable Films Manufacturers and is a valuable method of obtaining guidance and direction for companies and business enterprise insider considering the Oral Dissolvable Films …

IntelGenx Grants Restricted Share Units

SAINT LAURENT, Quebec, Dec. 26, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTC.QX:IGXT) announced today that the Company’s board of directors granted Restricted Share Units (RSU’s) to acquire a total of 53,846 common shares under the Company…
Show more

IntelGenx Frequently Asked Questions

  • When was IntelGenx founded?

    IntelGenx was founded in 2003.

  • How many employees does IntelGenx have?

    IntelGenx has 38 employees.

  • What is IntelGenx revenue?

    Latest IntelGenx annual revenue is $1.8 m.

  • What is IntelGenx revenue per employee?

    Latest IntelGenx revenue per employee is $48 k.

  • Who are IntelGenx competitors?

    Competitors of IntelGenx include Mylan, Generex Biotechnology and Amphastar Pharmaceuticals.

  • Where is IntelGenx headquarters?

    IntelGenx headquarters is located at 6420 Rue Abrams, Saint-Laurent.

  • Where are IntelGenx offices?

    IntelGenx has an office in Saint-Laurent.

  • How many offices does IntelGenx have?

    IntelGenx has 1 office.